Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 70 | 2024 | 3763 | 6.580 |
Why?
|
Bone Resorption | 21 | 2023 | 723 | 3.730 |
Why?
|
Spondylarthritis | 8 | 2022 | 61 | 3.480 |
Why?
|
Osteoclasts | 23 | 2023 | 711 | 3.090 |
Why?
|
Rheumatology | 14 | 2024 | 615 | 2.650 |
Why?
|
Arthritis, Experimental | 13 | 2016 | 291 | 2.380 |
Why?
|
Synovial Membrane | 20 | 2024 | 532 | 2.250 |
Why?
|
Bone and Bones | 21 | 2023 | 2568 | 2.110 |
Why?
|
Osteogenesis | 13 | 2023 | 1273 | 2.110 |
Why?
|
Rheumatic Diseases | 15 | 2023 | 649 | 2.090 |
Why?
|
Osteoblasts | 14 | 2023 | 1143 | 1.990 |
Why?
|
Endodeoxyribonucleases | 6 | 2020 | 164 | 1.820 |
Why?
|
Arthritis, Psoriatic | 4 | 2024 | 219 | 1.170 |
Why?
|
Teriparatide | 3 | 2020 | 227 | 1.160 |
Why?
|
Toll-Like Receptors | 5 | 2020 | 589 | 1.150 |
Why?
|
Inflammation | 20 | 2024 | 10773 | 0.990 |
Why?
|
Antirheumatic Agents | 11 | 2024 | 1372 | 0.970 |
Why?
|
RANK Ligand | 11 | 2023 | 318 | 0.920 |
Why?
|
Bone Remodeling | 5 | 2016 | 581 | 0.900 |
Why?
|
Interferons | 3 | 2023 | 706 | 0.850 |
Why?
|
Joints | 7 | 2019 | 322 | 0.830 |
Why?
|
Hereditary Autoinflammatory Diseases | 1 | 2022 | 42 | 0.800 |
Why?
|
Interleukin-17 | 3 | 2020 | 912 | 0.780 |
Why?
|
Interleukin-23 | 2 | 2024 | 201 | 0.760 |
Why?
|
Vasculitis | 2 | 2024 | 521 | 0.690 |
Why?
|
Osteoarthritis | 6 | 2024 | 1063 | 0.690 |
Why?
|
Musculoskeletal Diseases | 5 | 2022 | 598 | 0.640 |
Why?
|
Membrane Glycoproteins | 10 | 2015 | 3702 | 0.610 |
Why?
|
Spondylarthropathies | 2 | 2010 | 14 | 0.610 |
Why?
|
Nucleic Acids | 2 | 2020 | 188 | 0.600 |
Why?
|
Signal Transduction | 16 | 2023 | 23445 | 0.590 |
Why?
|
Spondylitis, Ankylosing | 3 | 2020 | 155 | 0.590 |
Why?
|
Cytokines | 13 | 2023 | 7396 | 0.570 |
Why?
|
Bone Diseases, Metabolic | 2 | 2017 | 409 | 0.550 |
Why?
|
Periosteum | 2 | 2019 | 139 | 0.540 |
Why?
|
Bone Morphogenetic Protein 3 | 1 | 2016 | 17 | 0.540 |
Why?
|
RNA, Messenger | 15 | 2016 | 12795 | 0.520 |
Why?
|
Tumor Necrosis Factor-alpha | 13 | 2020 | 4352 | 0.500 |
Why?
|
Societies, Medical | 4 | 2021 | 3905 | 0.500 |
Why?
|
Autoimmune Diseases | 4 | 2022 | 2244 | 0.500 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 9 | 2016 | 77 | 0.500 |
Why?
|
Autoantibodies | 5 | 2022 | 2116 | 0.490 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2024 | 2155 | 0.480 |
Why?
|
Bone Development | 3 | 2017 | 472 | 0.460 |
Why?
|
Animals | 62 | 2024 | 168459 | 0.450 |
Why?
|
Bone Density Conservation Agents | 2 | 2020 | 795 | 0.450 |
Why?
|
Arthritis | 7 | 2015 | 680 | 0.440 |
Why?
|
Fibrin | 3 | 2020 | 507 | 0.440 |
Why?
|
RNA | 4 | 2020 | 2726 | 0.430 |
Why?
|
Wnt Proteins | 3 | 2012 | 718 | 0.430 |
Why?
|
Mice | 44 | 2024 | 81525 | 0.420 |
Why?
|
Receptors, Tumor Necrosis Factor | 8 | 2006 | 585 | 0.410 |
Why?
|
Glycoproteins | 10 | 2009 | 2203 | 0.400 |
Why?
|
Mice, Inbred C57BL | 19 | 2023 | 22169 | 0.370 |
Why?
|
Carrier Proteins | 8 | 2014 | 4936 | 0.360 |
Why?
|
Cell Differentiation | 17 | 2023 | 11528 | 0.360 |
Why?
|
DNA-Binding Proteins | 15 | 2023 | 9606 | 0.360 |
Why?
|
Antibody Formation | 2 | 2014 | 1395 | 0.350 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.340 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 6 | 2006 | 857 | 0.340 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 918 | 0.340 |
Why?
|
Humans | 111 | 2024 | 761504 | 0.330 |
Why?
|
Bone Diseases | 2 | 2009 | 418 | 0.330 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1463 | 0.320 |
Why?
|
Osteoprotegerin | 7 | 2016 | 176 | 0.320 |
Why?
|
Bone Density | 4 | 2017 | 3551 | 0.310 |
Why?
|
Metacarpophalangeal Joint | 2 | 2020 | 82 | 0.310 |
Why?
|
Metalloendopeptidases | 3 | 1996 | 393 | 0.300 |
Why?
|
Collagenases | 3 | 2005 | 222 | 0.300 |
Why?
|
Alternative Splicing | 1 | 2013 | 1093 | 0.300 |
Why?
|
Mice, Knockout | 13 | 2020 | 14414 | 0.290 |
Why?
|
Biological Products | 1 | 2016 | 914 | 0.290 |
Why?
|
Autoimmunity | 4 | 2022 | 1356 | 0.290 |
Why?
|
Membrane Proteins | 6 | 2020 | 7856 | 0.280 |
Why?
|
Osteoporosis | 3 | 2019 | 1606 | 0.270 |
Why?
|
Methotrexate | 2 | 2024 | 1719 | 0.270 |
Why?
|
Synovitis | 3 | 2019 | 217 | 0.270 |
Why?
|
Synovitis, Pigmented Villonodular | 2 | 1997 | 32 | 0.260 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2009 | 396 | 0.260 |
Why?
|
Sialoglycoproteins | 2 | 2004 | 315 | 0.260 |
Why?
|
Inflammation Mediators | 4 | 2015 | 1886 | 0.240 |
Why?
|
Advisory Committees | 4 | 2021 | 787 | 0.240 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9177 | 0.240 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2022 | 1651 | 0.230 |
Why?
|
Th1 Cells | 2 | 2019 | 1036 | 0.220 |
Why?
|
MicroRNAs | 2 | 2016 | 3816 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3051 | 0.220 |
Why?
|
X-Ray Microtomography | 3 | 2022 | 456 | 0.220 |
Why?
|
Glucocorticoids | 3 | 2024 | 2161 | 0.210 |
Why?
|
Chondrocalcinosis | 1 | 2024 | 84 | 0.210 |
Why?
|
Histocompatibility Antigens Class II | 5 | 2019 | 1435 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 4575 | 0.200 |
Why?
|
Macrophages | 7 | 2016 | 5769 | 0.190 |
Why?
|
Acid Phosphatase | 4 | 2012 | 139 | 0.190 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2024 | 323 | 0.190 |
Why?
|
Neutrophils | 4 | 2022 | 3767 | 0.190 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2003 | 278 | 0.180 |
Why?
|
Disease Models, Animal | 11 | 2022 | 18252 | 0.180 |
Why?
|
Lyme Disease | 2 | 1998 | 631 | 0.170 |
Why?
|
Inflammasomes | 2 | 2016 | 526 | 0.170 |
Why?
|
In Situ Hybridization | 6 | 2009 | 1900 | 0.170 |
Why?
|
Peer Review, Research | 1 | 2003 | 340 | 0.170 |
Why?
|
Finger Joint | 1 | 2020 | 108 | 0.170 |
Why?
|
Polymyositis | 1 | 2000 | 75 | 0.170 |
Why?
|
Amyloidosis | 2 | 2000 | 817 | 0.170 |
Why?
|
Diphosphonates | 1 | 2004 | 636 | 0.160 |
Why?
|
Gene Expression Profiling | 5 | 2019 | 9420 | 0.160 |
Why?
|
Truth Disclosure | 1 | 2003 | 434 | 0.160 |
Why?
|
Membrane Transport Proteins | 3 | 2020 | 1035 | 0.160 |
Why?
|
Blotting, Western | 4 | 2016 | 5035 | 0.160 |
Why?
|
Interleukin-1 | 5 | 2003 | 1248 | 0.160 |
Why?
|
Myocarditis | 2 | 1998 | 788 | 0.160 |
Why?
|
NFATC Transcription Factors | 5 | 2016 | 389 | 0.160 |
Why?
|
Editorial Policies | 1 | 2003 | 458 | 0.150 |
Why?
|
Fibroblasts | 6 | 2024 | 4141 | 0.150 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10194 | 0.150 |
Why?
|
Conflict of Interest | 1 | 2003 | 554 | 0.150 |
Why?
|
Ligands | 2 | 2023 | 3272 | 0.150 |
Why?
|
Mucin-5B | 1 | 2018 | 148 | 0.150 |
Why?
|
Lipopolysaccharides | 4 | 2005 | 2206 | 0.150 |
Why?
|
Toll-Like Receptor 7 | 2 | 2015 | 177 | 0.150 |
Why?
|
Immunosuppressive Agents | 2 | 2020 | 4174 | 0.140 |
Why?
|
Education, Distance | 1 | 2021 | 261 | 0.140 |
Why?
|
Disclosure | 1 | 2003 | 748 | 0.140 |
Why?
|
Giant Cell Tumors | 1 | 1997 | 89 | 0.140 |
Why?
|
DNA | 4 | 2022 | 7212 | 0.140 |
Why?
|
Knee Joint | 3 | 2013 | 1676 | 0.140 |
Why?
|
Fenretinide | 1 | 1996 | 9 | 0.140 |
Why?
|
Interleukin-4 | 5 | 1998 | 1149 | 0.140 |
Why?
|
Biological Therapy | 1 | 2018 | 141 | 0.140 |
Why?
|
Ulna | 1 | 2017 | 134 | 0.140 |
Why?
|
Hand Bones | 1 | 2016 | 13 | 0.130 |
Why?
|
Endosomes | 2 | 2016 | 522 | 0.130 |
Why?
|
Male | 39 | 2024 | 360804 | 0.130 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2016 | 86 | 0.130 |
Why?
|
Fractures, Bone | 2 | 2024 | 2046 | 0.130 |
Why?
|
Cells, Cultured | 7 | 2024 | 18965 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2021 | 803 | 0.130 |
Why?
|
Polymerase Chain Reaction | 3 | 2016 | 6075 | 0.130 |
Why?
|
Familial Mediterranean Fever | 1 | 2016 | 65 | 0.130 |
Why?
|
Immunologic Factors | 2 | 2023 | 1589 | 0.130 |
Why?
|
NF-kappa B | 4 | 2014 | 2490 | 0.130 |
Why?
|
Hand Joints | 1 | 2016 | 58 | 0.130 |
Why?
|
Toll-Like Receptor 3 | 1 | 2015 | 98 | 0.120 |
Why?
|
Immunohistochemistry | 9 | 2009 | 11076 | 0.120 |
Why?
|
Genes, MHC Class II | 3 | 1995 | 434 | 0.120 |
Why?
|
Vaccination | 3 | 2022 | 3384 | 0.120 |
Why?
|
Polyarteritis Nodosa | 1 | 1995 | 70 | 0.120 |
Why?
|
Mycobacterium Infections | 1 | 1995 | 122 | 0.120 |
Why?
|
Interleukin-1beta | 3 | 2016 | 999 | 0.120 |
Why?
|
Female | 42 | 2024 | 392644 | 0.120 |
Why?
|
Myxoma | 1 | 1995 | 114 | 0.120 |
Why?
|
Toll-Like Receptor 5 | 1 | 2014 | 42 | 0.120 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 1994 | 40 | 0.120 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2014 | 42 | 0.120 |
Why?
|
Interferon Regulatory Factors | 1 | 2015 | 261 | 0.120 |
Why?
|
Radius | 1 | 2017 | 441 | 0.120 |
Why?
|
Radiography | 5 | 2013 | 6965 | 0.110 |
Why?
|
Interferon-gamma | 2 | 2019 | 3162 | 0.110 |
Why?
|
Dependovirus | 1 | 2019 | 718 | 0.110 |
Why?
|
Myeloid Progenitor Cells | 1 | 2014 | 113 | 0.110 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2015 | 306 | 0.110 |
Why?
|
Transcription Factors | 9 | 2005 | 12128 | 0.110 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 435 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7390 | 0.110 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4544 | 0.110 |
Why?
|
Isoenzymes | 3 | 2012 | 1687 | 0.110 |
Why?
|
Muscular Diseases | 2 | 2022 | 553 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2019 | 2020 | 0.110 |
Why?
|
Collagen Type II | 1 | 2014 | 148 | 0.110 |
Why?
|
Flow Cytometry | 3 | 2019 | 5869 | 0.110 |
Why?
|
Peritoneum | 1 | 2014 | 225 | 0.110 |
Why?
|
Posterior Cruciate Ligament | 1 | 2013 | 85 | 0.110 |
Why?
|
Blood Sedimentation | 1 | 2014 | 235 | 0.110 |
Why?
|
Angiopoietin-1 | 2 | 2004 | 122 | 0.110 |
Why?
|
Gene Silencing | 1 | 2019 | 1509 | 0.100 |
Why?
|
Middle Aged | 31 | 2024 | 220895 | 0.100 |
Why?
|
Sirolimus | 1 | 2020 | 1533 | 0.100 |
Why?
|
Delphi Technique | 3 | 2021 | 846 | 0.100 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2016 | 842 | 0.100 |
Why?
|
Tendons | 1 | 1997 | 558 | 0.100 |
Why?
|
Severity of Illness Index | 6 | 2020 | 15842 | 0.100 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 934 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.100 |
Why?
|
Cartilage | 5 | 2019 | 806 | 0.100 |
Why?
|
Cathepsins | 3 | 2006 | 241 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.100 |
Why?
|
Follistatin-Related Proteins | 1 | 2012 | 48 | 0.100 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2628 | 0.100 |
Why?
|
Hand | 3 | 2009 | 902 | 0.100 |
Why?
|
Respiration | 1 | 2018 | 1657 | 0.100 |
Why?
|
Peritonitis | 1 | 2014 | 368 | 0.100 |
Why?
|
DNA Primers | 3 | 2009 | 2819 | 0.100 |
Why?
|
Heart Neoplasms | 1 | 1995 | 362 | 0.100 |
Why?
|
Arthritis, Infectious | 1 | 1995 | 347 | 0.100 |
Why?
|
Jurkat Cells | 1 | 2013 | 740 | 0.100 |
Why?
|
B-Lymphocytes | 7 | 2023 | 4758 | 0.100 |
Why?
|
Skull | 1 | 2016 | 818 | 0.090 |
Why?
|
Cartilage, Articular | 2 | 2013 | 1099 | 0.090 |
Why?
|
Aged | 23 | 2024 | 169289 | 0.090 |
Why?
|
beta 2-Microglobulin | 1 | 1992 | 329 | 0.090 |
Why?
|
Microbial Collagenase | 1 | 1991 | 112 | 0.090 |
Why?
|
Up-Regulation | 4 | 2013 | 4124 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.090 |
Why?
|
Myeloid Cells | 1 | 2015 | 823 | 0.090 |
Why?
|
Drug Approval | 1 | 2018 | 814 | 0.090 |
Why?
|
Pandemics | 5 | 2021 | 8654 | 0.090 |
Why?
|
Antigens, CD | 4 | 2006 | 4003 | 0.090 |
Why?
|
Autoantigens | 1 | 2014 | 891 | 0.090 |
Why?
|
Monocytes | 4 | 2019 | 2570 | 0.090 |
Why?
|
Stromal Cells | 1 | 2016 | 1330 | 0.090 |
Why?
|
Prosthesis-Related Infections | 1 | 1995 | 488 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 1995 | 1204 | 0.090 |
Why?
|
Anterior Cruciate Ligament | 1 | 2013 | 423 | 0.090 |
Why?
|
Gene Expression | 6 | 2024 | 7581 | 0.090 |
Why?
|
Nucleic Acid Hybridization | 1 | 1991 | 1302 | 0.090 |
Why?
|
Synovial Fluid | 3 | 2018 | 393 | 0.080 |
Why?
|
Blotting, Northern | 3 | 2003 | 1545 | 0.080 |
Why?
|
Matrix Metalloproteinase 3 | 3 | 1996 | 138 | 0.080 |
Why?
|
Crohn Disease | 2 | 1995 | 2279 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2019 | 9000 | 0.080 |
Why?
|
Hip Prosthesis | 1 | 1995 | 921 | 0.080 |
Why?
|
Down-Regulation | 1 | 2016 | 2919 | 0.080 |
Why?
|
Gadolinium | 1 | 2014 | 960 | 0.080 |
Why?
|
Bone Regeneration | 1 | 2012 | 432 | 0.080 |
Why?
|
Metacarpal Bones | 1 | 2009 | 75 | 0.080 |
Why?
|
Calcification, Physiologic | 1 | 2009 | 170 | 0.080 |
Why?
|
Chondrocytes | 3 | 2018 | 795 | 0.080 |
Why?
|
Rats | 2 | 2022 | 23742 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2013 | 1699 | 0.080 |
Why?
|
Cohort Studies | 6 | 2024 | 41487 | 0.080 |
Why?
|
Aortitis | 1 | 1989 | 74 | 0.080 |
Why?
|
Transcription, Genetic | 5 | 2004 | 7594 | 0.070 |
Why?
|
Blood Vessels | 1 | 2013 | 1113 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2014 | 2707 | 0.070 |
Why?
|
Cathepsin K | 3 | 2006 | 65 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 3 | 2005 | 4511 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2872 | 0.070 |
Why?
|
Base Sequence | 6 | 2009 | 12441 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 1995 | 1993 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2226 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2898 | 0.070 |
Why?
|
Mice, Inbred DBA | 3 | 2014 | 621 | 0.070 |
Why?
|
Spine | 2 | 2009 | 1118 | 0.070 |
Why?
|
Immunity, Innate | 2 | 2016 | 3065 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2017 | 64680 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2013 | 1530 | 0.060 |
Why?
|
Hip Joint | 2 | 2009 | 1014 | 0.060 |
Why?
|
Proteins | 1 | 2000 | 6032 | 0.060 |
Why?
|
Phenotype | 4 | 2023 | 16591 | 0.060 |
Why?
|
Mice, Inbred C3H | 2 | 1998 | 915 | 0.060 |
Why?
|
Osteopontin | 2 | 2004 | 301 | 0.060 |
Why?
|
Lymphocyte Activation | 3 | 2013 | 5486 | 0.060 |
Why?
|
United States | 9 | 2022 | 72334 | 0.060 |
Why?
|
Prostaglandins | 1 | 2005 | 398 | 0.060 |
Why?
|
Enzyme Induction | 1 | 2005 | 452 | 0.060 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2005 | 327 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20570 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 318 | 0.060 |
Why?
|
Osteolysis | 1 | 2006 | 275 | 0.060 |
Why?
|
Calcium Pyrophosphate | 1 | 2024 | 55 | 0.060 |
Why?
|
Immunoenzyme Techniques | 3 | 2003 | 1705 | 0.060 |
Why?
|
Collagen | 3 | 2014 | 2638 | 0.060 |
Why?
|
Hospitalization | 2 | 2020 | 10723 | 0.050 |
Why?
|
Rheumatoid Factor | 1 | 2024 | 185 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2016 | 3396 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2012 | 9539 | 0.050 |
Why?
|
Osteoarthritis, Knee | 1 | 2013 | 1234 | 0.050 |
Why?
|
Receptors, Calcitonin | 2 | 2006 | 34 | 0.050 |
Why?
|
Arthroplasty, Replacement | 1 | 2006 | 310 | 0.050 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2002 | 23 | 0.050 |
Why?
|
Culture Techniques | 1 | 2003 | 531 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3826 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2023 | 17904 | 0.050 |
Why?
|
Angiopoietin-2 | 1 | 2003 | 172 | 0.050 |
Why?
|
Cystadenocarcinoma, Papillary | 1 | 2001 | 56 | 0.050 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2006 | 283 | 0.050 |
Why?
|
Prosthesis Implantation | 1 | 2006 | 592 | 0.050 |
Why?
|
Nuclear Proteins | 4 | 2005 | 5796 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6310 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 4 | 1 | 2000 | 5 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 5 | 1 | 2000 | 5 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 3123 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2000 | 38 | 0.050 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2000 | 44 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2000 | 48 | 0.050 |
Why?
|
Contrast Media | 1 | 2014 | 5311 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2000 | 56 | 0.050 |
Why?
|
Antibodies | 2 | 2014 | 2418 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 1171 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2005 | 286 | 0.050 |
Why?
|
Interleukins | 2 | 2000 | 782 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2000 | 61 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14605 | 0.040 |
Why?
|
Rats, Transgenic | 1 | 2020 | 69 | 0.040 |
Why?
|
Paraneoplastic Syndromes | 1 | 2001 | 155 | 0.040 |
Why?
|
Remission Induction | 2 | 2019 | 2396 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13380 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2000 | 186 | 0.040 |
Why?
|
Myofibrils | 1 | 2000 | 141 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 2 | 2015 | 262 | 0.040 |
Why?
|
Fingers | 2 | 1995 | 507 | 0.040 |
Why?
|
Health Surveys | 1 | 2009 | 4061 | 0.040 |
Why?
|
Linear Models | 1 | 2009 | 5871 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2004 | 1991 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2021 | 318 | 0.040 |
Why?
|
Adult | 13 | 2022 | 221177 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 3 | 2005 | 314 | 0.040 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2000 | 118 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2001 | 12974 | 0.040 |
Why?
|
Dermatomyositis | 1 | 2001 | 258 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 16981 | 0.040 |
Why?
|
Chondrogenesis | 1 | 2000 | 239 | 0.040 |
Why?
|
Imidazoles | 1 | 2004 | 1180 | 0.040 |
Why?
|
beta Catenin | 1 | 2023 | 1040 | 0.040 |
Why?
|
Plasma Cells | 1 | 2001 | 599 | 0.040 |
Why?
|
Triamcinolone Acetonide | 1 | 2018 | 100 | 0.040 |
Why?
|
Vitronectin | 1 | 1997 | 40 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8830 | 0.040 |
Why?
|
Receptors, Parathyroid Hormone | 1 | 1998 | 332 | 0.040 |
Why?
|
Risk Factors | 4 | 2023 | 74206 | 0.030 |
Why?
|
Epitopes | 1 | 2003 | 2503 | 0.030 |
Why?
|
Capsid | 1 | 2019 | 435 | 0.030 |
Why?
|
Pilot Projects | 3 | 2019 | 8631 | 0.030 |
Why?
|
Polyisoprenyl Phosphates | 1 | 2016 | 38 | 0.030 |
Why?
|
Biopsy | 3 | 2000 | 6766 | 0.030 |
Why?
|
Heart Valves | 1 | 1998 | 284 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 1998 | 445 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 1988 | 1922 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 588 | 0.030 |
Why?
|
Mice, Inbred BALB C | 3 | 2019 | 6216 | 0.030 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58976 | 0.030 |
Why?
|
Radiation Chimera | 1 | 2016 | 216 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2865 | 0.030 |
Why?
|
Interferon Type I | 1 | 2019 | 562 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12059 | 0.030 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2015 | 53 | 0.030 |
Why?
|
NF-kappa B p50 Subunit | 1 | 1995 | 103 | 0.030 |
Why?
|
Attitude | 1 | 2020 | 775 | 0.030 |
Why?
|
Hydroxyurea | 1 | 2016 | 284 | 0.030 |
Why?
|
Aorta, Thoracic | 2 | 1994 | 1096 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 1997 | 602 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2016 | 226 | 0.030 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2015 | 112 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2000 | 1229 | 0.030 |
Why?
|
Borrelia burgdorferi Group | 1 | 1995 | 97 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22176 | 0.030 |
Why?
|
Splenomegaly | 1 | 2015 | 189 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2001 | 1298 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 1995 | 254 | 0.030 |
Why?
|
Mutation | 3 | 2016 | 30052 | 0.030 |
Why?
|
Chemotactic Factors | 1 | 1995 | 197 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2000 | 13639 | 0.030 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1995 | 317 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2015 | 233 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 851 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 1995 | 200 | 0.030 |
Why?
|
Flagellin | 1 | 2014 | 124 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 1995 | 302 | 0.030 |
Why?
|
Gout | 2 | 1993 | 621 | 0.030 |
Why?
|
Immunoglobulin M | 2 | 1998 | 1527 | 0.030 |
Why?
|
B-Lymphocyte Subsets | 1 | 1995 | 239 | 0.030 |
Why?
|
Toll-Like Receptor 2 | 1 | 2015 | 347 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1039 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2016 | 559 | 0.030 |
Why?
|
Trans-Activators | 1 | 2003 | 2856 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1516 | 0.030 |
Why?
|
Endocrine Glands | 1 | 1993 | 102 | 0.030 |
Why?
|
Acute Disease | 1 | 2024 | 7237 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2005 | 17635 | 0.030 |
Why?
|
Cryopreservation | 1 | 2018 | 728 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1995 | 586 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1844 | 0.030 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2014 | 159 | 0.030 |
Why?
|
Luciferases | 2 | 2005 | 714 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 981 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2014 | 250 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22170 | 0.030 |
Why?
|
Lymphopenia | 1 | 1995 | 281 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2014 | 698 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 441 | 0.030 |
Why?
|
Cell Movement | 2 | 2014 | 5203 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1993 | 420 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5336 | 0.030 |
Why?
|
Hydrogels | 1 | 2018 | 720 | 0.030 |
Why?
|
Disease Progression | 3 | 2004 | 13506 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2011 | 8002 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 1995 | 605 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2000 | 2416 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 1995 | 4369 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 579 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2005 | 3778 | 0.020 |
Why?
|
Antigens, CD19 | 1 | 1995 | 424 | 0.020 |
Why?
|
Knee Prosthesis | 1 | 1995 | 395 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2665 | 0.020 |
Why?
|
Hindlimb | 1 | 2014 | 513 | 0.020 |
Why?
|
Cycloheximide | 1 | 1991 | 343 | 0.020 |
Why?
|
Drug Industry | 1 | 2018 | 788 | 0.020 |
Why?
|
Arthralgia | 1 | 1995 | 461 | 0.020 |
Why?
|
Metalloproteins | 1 | 1991 | 101 | 0.020 |
Why?
|
Interleukin-6 | 2 | 2016 | 3208 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1612 | 0.020 |
Why?
|
Leukocytes | 1 | 2019 | 2026 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1802 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2014 | 823 | 0.020 |
Why?
|
Promoter Regions, Genetic | 4 | 2005 | 5789 | 0.020 |
Why?
|
Hip | 1 | 1992 | 255 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2005 | 1529 | 0.020 |
Why?
|
Arthrography | 1 | 2011 | 150 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2014 | 647 | 0.020 |
Why?
|
Wrist | 1 | 1992 | 227 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2319 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2004 | 11903 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2273 | 0.020 |
Why?
|
Shoulder | 1 | 1992 | 300 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1991 | 1141 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1685 | 0.020 |
Why?
|
Osteitis | 1 | 2009 | 33 | 0.020 |
Why?
|
Rheumatoid Nodule | 1 | 1989 | 15 | 0.020 |
Why?
|
Phosphorylation | 2 | 2014 | 8320 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1664 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2395 | 0.020 |
Why?
|
Mice, Nude | 2 | 2000 | 3615 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1135 | 0.020 |
Why?
|
Pain | 1 | 2024 | 5073 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 1995 | 1469 | 0.020 |
Why?
|
Spondylitis | 1 | 1988 | 20 | 0.020 |
Why?
|
Deoxyribonuclease I | 1 | 1989 | 224 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1413 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2019 | 1393 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1809 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1974 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1996 | 4853 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2449 | 0.020 |
Why?
|
Fever | 1 | 1995 | 1618 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2000 | 2529 | 0.020 |
Why?
|
Cell Line | 4 | 2005 | 15601 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3518 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3639 | 0.020 |
Why?
|
Ischemia | 1 | 1995 | 1882 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 1997 | 1935 | 0.020 |
Why?
|
Arthroscopy | 1 | 1993 | 969 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 1989 | 625 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3712 | 0.020 |
Why?
|
Fos-Related Antigen-2 | 1 | 2005 | 14 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.020 |
Why?
|
Smad1 Protein | 1 | 2005 | 81 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21353 | 0.020 |
Why?
|
Langerhans Cells | 1 | 1986 | 170 | 0.020 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2005 | 102 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80636 | 0.020 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 158 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1336 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2000 | 4948 | 0.020 |
Why?
|
Cell Cycle | 2 | 2005 | 2932 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2001 | 4876 | 0.010 |
Why?
|
Liver | 2 | 1998 | 7529 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26125 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5890 | 0.010 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2005 | 343 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1738 | 0.010 |
Why?
|
Spleen | 1 | 1989 | 2295 | 0.010 |
Why?
|
Stevens-Johnson Syndrome | 1 | 1986 | 246 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2005 | 878 | 0.010 |
Why?
|
Child, Preschool | 1 | 2006 | 42230 | 0.010 |
Why?
|
Tarsus, Animal | 1 | 2002 | 5 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 2003 | 416 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1994 | 3466 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 597 | 0.010 |
Why?
|
Cell Division | 2 | 2000 | 4465 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1991 | 2547 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 321 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2004 | 670 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2000 | 5146 | 0.010 |
Why?
|
Back | 1 | 2001 | 64 | 0.010 |
Why?
|
Myocardium | 1 | 1995 | 4726 | 0.010 |
Why?
|
Forehead | 1 | 2001 | 75 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 256 | 0.010 |
Why?
|
Pain Measurement | 1 | 2011 | 3550 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12990 | 0.010 |
Why?
|
Recovery of Function | 1 | 2011 | 2979 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10445 | 0.010 |
Why?
|
Chemotaxis | 1 | 2004 | 598 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2004 | 582 | 0.010 |
Why?
|
Postmenopause | 1 | 2009 | 2513 | 0.010 |
Why?
|
Polyomavirus | 1 | 2001 | 234 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2004 | 1693 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1989 | 2909 | 0.010 |
Why?
|
Plasmids | 1 | 2005 | 2269 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 344 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2009 | 1879 | 0.010 |
Why?
|
Chimera | 1 | 2001 | 453 | 0.010 |
Why?
|
Immunization, Passive | 1 | 2002 | 616 | 0.010 |
Why?
|
Tibia | 1 | 2005 | 1070 | 0.010 |
Why?
|
Mitomycin | 1 | 2000 | 263 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36426 | 0.010 |
Why?
|
Femur | 1 | 2005 | 1307 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2011 | 3461 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 1980 | 439 | 0.010 |
Why?
|
Thorax | 1 | 2001 | 555 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14031 | 0.010 |
Why?
|
Endopeptidases | 1 | 2002 | 774 | 0.010 |
Why?
|
Health Status | 1 | 2011 | 4077 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8224 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1961 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2004 | 1756 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20098 | 0.010 |
Why?
|
Child | 1 | 2006 | 80153 | 0.010 |
Why?
|
Adolescent | 1 | 2006 | 88319 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5774 | 0.010 |
Why?
|
Calcineurin | 1 | 1998 | 229 | 0.010 |
Why?
|
Apoptosis | 2 | 2005 | 9486 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2001 | 1870 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2005 | 3429 | 0.010 |
Why?
|
Time Factors | 2 | 2009 | 39967 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54425 | 0.010 |
Why?
|
Deoxycytidine | 1 | 2000 | 877 | 0.010 |
Why?
|
Antigens | 1 | 2001 | 1443 | 0.010 |
Why?
|
DNA Damage | 1 | 2005 | 2446 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2000 | 1062 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 4111 | 0.010 |
Why?
|
Binding Sites | 1 | 2004 | 6055 | 0.010 |
Why?
|
Blood Proteins | 1 | 1980 | 1173 | 0.010 |
Why?
|
Gene Targeting | 1 | 1998 | 838 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2000 | 2218 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2004 | 3395 | 0.010 |
Why?
|
Morphogenesis | 1 | 1998 | 741 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 1993 | 97 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1997 | 1572 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18395 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6132 | 0.010 |
Why?
|
Vibrissae | 1 | 1993 | 116 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2000 | 3602 | 0.010 |
Why?
|
Salivary Glands | 1 | 1993 | 229 | 0.010 |
Why?
|
Tooth | 1 | 1993 | 210 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9351 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 1998 | 1502 | 0.010 |
Why?
|
Erythrocytes | 1 | 1980 | 2413 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1993 | 864 | 0.010 |
Why?
|
Quality of Life | 1 | 2011 | 13367 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 3734 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2000 | 2538 | 0.000 |
Why?
|
Stem Cells | 1 | 2000 | 3522 | 0.000 |
Why?
|
Prochlorperazine | 1 | 1986 | 16 | 0.000 |
Why?
|
Alleles | 1 | 1998 | 6863 | 0.000 |
Why?
|
Pancreas | 1 | 1993 | 1691 | 0.000 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1990 | 790 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4431 | 0.000 |
Why?
|
Epidermis | 1 | 1986 | 528 | 0.000 |
Why?
|
Enhancer Elements, Genetic | 1 | 1990 | 1363 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 2000 | 6346 | 0.000 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2000 | 5315 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 1980 | 5840 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1993 | 3312 | 0.000 |
Why?
|
Borohydrides | 1 | 1980 | 32 | 0.000 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1986 | 974 | 0.000 |
Why?
|
Models, Genetic | 1 | 1990 | 3442 | 0.000 |
Why?
|
Anemia, Hemolytic | 1 | 1980 | 162 | 0.000 |
Why?
|
Graft vs Host Disease | 1 | 1986 | 3029 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1980 | 1315 | 0.000 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1986 | 3080 | 0.000 |
Why?
|
Pregnancy | 1 | 1993 | 29874 | 0.000 |
Why?
|